Y. Pinto

Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

F. D. de Man, H. Bogaard, E. Duijvelaar, 2022, Journal of cardiovascular pharmacology.

Evaluation of polygenic score for hypertrophic cardiomyopathy in the general population and across clinical settings

D. O’Regan, Wenjia Bai, A. Marvao, 2023, medRxiv.

Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy

O. Kamp, A. Rossum, T. Germans, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Dealing with a new disease

Y. Pinto, 2022, Netherlands Heart Journal.